StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Nutra Pharma's pe ratio was 0.3× on Jan 31, 2024, against 0.1× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20240.3×+0.0
2023Dec 29, 20230.3×+0.2
2022Dec 30, 20220.1×–

More Nutra Pharma figures

See a number that looks wrong?